Clinical Trial Update: Boceprevir and Ucalm (St John&Apos;s Wort) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and potential drug interaction between Boceprevir and St John's Wort (Ucalm) in Hepatitis C; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)
• Ucalm (St John's wort)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2014-09-29